Ekosonic
Payments companies reported to CMS as associated with Ekosonic. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ekosonic, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ekosonic
These are the largest totals companies reported as associated with Ekosonic. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Monteleone | Kyle, TX | Interventional Cardiology | $128,040.56 |
| Patrick Troy | Hartford, CT | Pulmonary Disease | $110,298.02 |
| Daniella Kadian Dodov | New York, NY | Internal Medicine | $78,105.04 |
| John Park | Omaha, NE | Vascular Surgery | $56,485.25 |
| Anas Safadi | Hobart, IN | Cardiovascular Disease | $49,721.57 |
| Nicholas Petruzzi | Galloway, NJ | Vascular & Interventional Radiology | $38,389.18 |
| Sanjum Sethi | New York, NY | Interventional Cardiology | $30,393.18 |
| Yulanka Castro Dominguez | Ashland, OH | Interventional Cardiology | $24,425.00 |
| Assaf Graif | Newark, DE | Vascular & Interventional Radiology | $24,312.44 |
| Christopher Semder | Louisville, KY | Interventional Cardiology | $19,682.92 |
Prescribed Ekosonic?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.